Marinomed Biotech AG MARI.VI Stock
Marinomed Biotech AG Price Chart
Marinomed Biotech AG MARI.VI Financial and Trading Overview
| Marinomed Biotech AG stock price | 19.85 EUR |
| Previous Close | 43.3 EUR |
| Open | 42.5 EUR |
| Bid | 42.7 EUR x 0 |
| Ask | 43.5 EUR x 0 |
| Day's Range | 42.5 - 43.5 EUR |
| 52 Week Range | 32.8 - 73.8 EUR |
| Volume | 350 EUR |
| Avg. Volume | 1.42K EUR |
| Market Cap | 65.77M EUR |
| Beta (5Y Monthly) | 0.073205 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.14 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 67.5 EUR |
MARI.VI Valuation Measures
| Enterprise Value | 81.72M EUR |
| Trailing P/E | N/A |
| Forward P/E | 39.545452 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 5.3984656 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 6.707 |
| Enterprise Value/EBITDA | -17.297 |
Trading Information
Marinomed Biotech AG Stock Price History
| Beta (5Y Monthly) | 0.073205 |
| 52-Week Change | -37.24% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 73.8 EUR |
| 52 Week Low | 32.8 EUR |
| 50-Day Moving Average | 38.32 EUR |
| 200-Day Moving Average | 49.89 EUR |
MARI.VI Share Statistics
| Avg. Volume (3 month) | 1.42K EUR |
| Avg. Daily Volume (10-Days) | 2.21K EUR |
| Shares Outstanding | 1.51M |
| Float | 1.06M |
| Short Ratio | N/A |
| % Held by Insiders | 37.72% |
| % Held by Institutions | 24.68% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -54.33% |
| Operating Margin (ttm) | -41.92% |
| Gross Margin | 15.11% |
| EBITDA Margin | -38.77% |
Management Effectiveness
| Return on Assets (ttm) | -14.10% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 12.18M EUR |
| Revenue Per Share (ttm) | 7.52 EUR |
| Quarterly Revenue Growth (yoy) | 37.60% |
| Gross Profit (ttm) | 1.88M EUR |
| EBITDA | -4724400 EUR |
| Net Income Avi to Common (ttm) | -6619900 EUR |
| Diluted EPS (ttm) | -4.48 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 7.02M EUR |
| Total Cash Per Share (mrq) | 4.62 EUR |
| Total Debt (mrq) | 21.9M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 2.461 |
| Book Value Per Share (mrq) | -2.76 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4979200 EUR |
| Levered Free Cash Flow (ttm) | -4098725 EUR |
Profile of Marinomed Biotech AG
| Country | Austria |
| State | N/A |
| City | Korneuburg |
| Address | Hovengasse 25 |
| ZIP | 2100 |
| Phone | 43 2262 90300 |
| Website | https://www.marinomed.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 36 |
Marinomed Biotech AG, a biopharmaceutical company, develops therapeutic products for indications in virology and immunology in Austria, other European countries, and internationally. Its products pipeline includes Budesolv for the treatment of allergic rhinitis and autoimmune gastritis; Tacrosolv, which is in Phase II clinical trial for anterior inflammatory eye diseases; Carravin for the treatment of nasal congestion; and Inhaleen that is in Phase I clinical trial for viral pneumonia, as well as Carragelose, which consists of nasal and throat sprays, and lozenges for treating viral respiratory infections. The company was formerly known as Marinomed Biotechnologie GmbH and changed its name to Marinomed Biotech AG in June 2017. Marinomed Biotech AG was incorporated in 2006 and is headquartered in Korneuburg, Austria.
Q&A For Marinomed Biotech AG Stock
What is a current MARI.VI stock price?
Marinomed Biotech AG MARI.VI stock price today per share is 19.85 EUR.
How to purchase Marinomed Biotech AG stock?
You can buy MARI.VI shares on the Vienna exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Marinomed Biotech AG?
The stock symbol or ticker of Marinomed Biotech AG is MARI.VI.
Which industry does the Marinomed Biotech AG company belong to?
The Marinomed Biotech AG industry is Biotechnology.
How many shares does Marinomed Biotech AG have in circulation?
The max supply of Marinomed Biotech AG shares is 1.54M.
What is Marinomed Biotech AG Price to Earnings Ratio (PE Ratio)?
Marinomed Biotech AG PE Ratio is now.
What was Marinomed Biotech AG earnings per share over the trailing 12 months (TTM)?
Marinomed Biotech AG EPS is -4.14 EUR over the trailing 12 months.
Which sector does the Marinomed Biotech AG company belong to?
The Marinomed Biotech AG sector is Healthcare.
Marinomed Biotech AG MARI.VI included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Wiener B?rse Index in EUR WBKI | 1409.26 EUR 1540.51 USD |
+0.28
|
— — | 1409.26 EUR 1540.51 USD | 1409.26 EUR 1540.51 USD | — - | — — |
| ATX Prime in EUR ATXPRIME | 1781.84 EUR 1947.79 USD |
+0.27
|
— — | 1776.43 EUR 1941.88 USD | 1795.95 EUR 1963.22 USD | — - | — — |
- {{ link.label }} {{link}}